Low Temperature and Low UV Indexes Correlated with Peaks of Influenza Virus Activity in Northern Europe during 2010⁻2018.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 11 01 2019
revised: 18 02 2019
accepted: 28 02 2019
entrez: 6 3 2019
pubmed: 6 3 2019
medline: 19 9 2019
Statut: epublish

Résumé

With the increasing pace of global warming, it is important to understand the role of meteorological factors in influenza virus (IV) epidemics. In this study, we investigated the impact of temperature, UV index, humidity, wind speed, atmospheric pressure, and precipitation on IV activity in Norway, Sweden, Finland, Estonia, Latvia and Lithuania during 2010⁻2018. Both correlation and machine learning analyses revealed that low temperature and UV indexes were the most predictive meteorological factors for IV epidemics in Northern Europe. Our in vitro experiments confirmed that low temperature and UV radiation preserved IV infectivity. Associations between these meteorological factors and IV activity could improve surveillance and promote development of accurate predictive models for future influenza outbreaks in the region.

Identifiants

pubmed: 30832226
pii: v11030207
doi: 10.3390/v11030207
pmc: PMC6466003
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Epidemiol Infect. 2009 Oct;137(10):1377-87
pubmed: 19296868
PLoS One. 2015 Aug 26;10(8):e0134701
pubmed: 26309214
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Virology. 2004 Jun 20;324(1):67-73
pubmed: 15183054
Am J Pathol. 2015 Jun;185(6):1528-36
pubmed: 25747532
Photochem Photobiol. 2007 Sep-Oct;83(5):1278-82
pubmed: 17880524
J Biol Chem. 2012 Oct 12;287(42):35324-32
pubmed: 22910914
Genome Announc. 2014 Jan 16;2(1):
pubmed: 24435855
BMC Public Health. 2016 May 26;16:441
pubmed: 27230111
PLoS Pathog. 2013 Mar;9(3):e1003194
pubmed: 23505366
Int J Environ Res Public Health. 2017 Nov 28;14(12):
pubmed: 29182525
Infect Ecol Epidemiol. 2018 May 16;8(1):1474708
pubmed: 29805785
J Virol. 2014 Jul;88(14):7692-5
pubmed: 24789791
Annu Rev Anim Biosci. 2015;3:347-73
pubmed: 25422855
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13081-13086
pubmed: 27799563
J Immunol. 1999 Jun 15;162(12):7322-9
pubmed: 10358182
PLoS Curr. 2013 Jan 28;5:
pubmed: 24045424
Appl Environ Microbiol. 2019 Mar 6;85(6):
pubmed: 30610079
J Virol. 1967 Dec;1(6):1207-16
pubmed: 5621490

Auteurs

Aleksandr Ianevski (A)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway. aleksandr.ianevski@ntnu.no.

Eva Zusinaite (E)

Institute of Technology, University of Tartu, 50090 Tartu, Estonia. eva.zusinaite@ut.ee.

Nastassia Shtaida (N)

Institute of Technology, University of Tartu, 50090 Tartu, Estonia. nastassia.shtaida@ut.ee.

Hannimari Kallio-Kokko (H)

Department of Virology and Immunology, University of Helsinki, 00014 Helsinki, Finland. hannimari.kallio-kokko@hus.fi.

Miia Valkonen (M)

Helsinki University Hospital (HUS) and University of Helsinki, 00290 Helsinki, Finland. miia.valkonen@hus.fi.

Anu Kantele (A)

Helsinki University Hospital (HUS) and University of Helsinki, 00290 Helsinki, Finland. anu.kantele@helsinki.fi.

Kaidi Telling (K)

Institute of Technology, University of Tartu, 50090 Tartu, Estonia. kaidi.telling@ut.ee.

Irja Lutsar (I)

Institute of Medical Microbiology, University of Tartu, 50411 Tartu, Estonia. irja.lutsar@ut.ee.

Pille Letjuka (P)

Narva Haigla, 20104 Narva, Estonia. ellipellip@mail.ru.

Natalja Metelitsa (N)

Narva Haigla, 20104 Narva, Estonia. nmetelitsa@gmail.com.

Valentyn Oksenych (V)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway. valentyn.oksenych@ntnu.no.

Uga Dumpis (U)

Latvian Biomedical Research and Study Centre, 1067 Riga, Latvia. uga.dumpis@gmail.com.

Astra Vitkauskiene (A)

Department of Laboratory Medicine, Lithuanian University of Health Science, 44307 Kaunas, Lithuania. astra.vitkauskiene@kaunoklinikos.lt.

Kestutis Stašaitis (K)

Department of Emergency Medicine, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania. kestutis.stasaitis@kaunoklinikos.lt.

Christina Öhrmalm (C)

Department of Medical Sciences, Uppsala University, 75309 Uppsala, Sweden. christina.ohrmalm@akademiska.se.

Kåre Bondeson (K)

Department of Medical Sciences, Uppsala University, 75309 Uppsala, Sweden. kare.bondeson@akademiska.se.

Anders Bergqvist (A)

Department of Medical Sciences, Uppsala University, 75309 Uppsala, Sweden. anders.bergqvist@akademiska.se.

Rebecca J Cox (RJ)

Influenza Centre, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway. rebecca.cox@uib.no.

Tanel Tenson (T)

Institute of Technology, University of Tartu, 50090 Tartu, Estonia. tanel.tenson@ut.ee.

Andres Merits (A)

Institute of Technology, University of Tartu, 50090 Tartu, Estonia. andres.merits@ut.ee.

Denis E Kainov (DE)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7028 Trondheim, Norway. denis.kainov@ntnu.no.
Institute of Technology, University of Tartu, 50090 Tartu, Estonia. denis.kainov@ntnu.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH